Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition
Julianty Frost, Carles Galdeano, Pedro Soares, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 200

Showing 1-25 of 200 citing articles:

Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd, Andrea Testa, Xavier Lucas, et al.
Nature Chemical Biology (2017) Vol. 13, Iss. 5, pp. 514-521
Open Access | Times Cited: 979
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem, Craig M. Crews
Cell (2020) Vol. 181, Iss. 1, pp. 102-114
Open Access | Times Cited: 780
PROteolysis TArgeting Chimeras (PROTACs) — Past, present and future
Mariell Pettersson, Craig M. Crews
Drug Discovery Today Technologies (2019) Vol. 31, pp. 15-27
Open Access | Times Cited: 601
PROTACs: past, present and future
Ke Li, Craig M. Crews
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5214-5236
Open Access | Times Cited: 426
CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide
Marie K. Schwinn, Thomas Machleidt, Kris Zimmerman, et al.
ACS Chemical Biology (2017) Vol. 13, Iss. 2, pp. 467-474
Open Access | Times Cited: 351
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
Xin Han, Chao Wang, Chong Qin, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 2, pp. 941-964
Closed Access | Times Cited: 334
Hypoxia induces rapid changes to histone methylation and reprograms chromatin
Michael Batie, Julianty Frost, Mark Frost, et al.
Science (2019) Vol. 363, Iss. 6432, pp. 1222-1226
Open Access | Times Cited: 326
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Vittoria Zoppi, Scott J. Hughes, Chiara Maniaci, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 2, pp. 699-726
Open Access | Times Cited: 296
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Kristin M. Riching, Sarah D. Mahan, Cesear Corona, et al.
ACS Chemical Biology (2018) Vol. 13, Iss. 9, pp. 2758-2770
Open Access | Times Cited: 266
Extracellular vesicle-loaded hydrogels for tissue repair and regeneration
Yikun Ju, Yue Hu, Yang Pu, et al.
Materials Today Bio (2022) Vol. 18, pp. 100522-100522
Open Access | Times Cited: 259
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Degradation of proteins by PROTACs and other strategies
Yang Wang, Xueyang Jiang, Feng Feng, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 2, pp. 207-238
Open Access | Times Cited: 255
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
Tasuku Ishida, Alessio Ciulli
SLAS DISCOVERY (2020) Vol. 26, Iss. 4, pp. 484-502
Open Access | Times Cited: 255
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area
Ran Xu, Jason E. Gestwicki
Current Opinion in Chemical Biology (2018) Vol. 44, pp. 75-86
Open Access | Times Cited: 233
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
Chiara Maniaci, Scott J. Hughes, Andrea Testa, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 215
Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
Scott J. Hughes, Alessio Ciulli
Essays in Biochemistry (2017) Vol. 61, Iss. 5, pp. 505-516
Open Access | Times Cited: 214
Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
Kwok-Ho Chan, Michael Zengerle, Andrea Testa, et al.
Journal of Medicinal Chemistry (2017) Vol. 61, Iss. 2, pp. 504-513
Open Access | Times Cited: 190
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
Satomi Imaide, Kristin M. Riching, Nikolai Makukhin, et al.
Nature Chemical Biology (2021) Vol. 17, Iss. 11, pp. 1157-1167
Open Access | Times Cited: 176
Proteolysis‐targeting chimeras in drug development: A safety perspective
Kévin Moreau, Muireann Coen, Andrew X. Zhang, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 8, pp. 1709-1718
Open Access | Times Cited: 164
Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation
Michael J. Bond, Craig M. Crews
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 725-742
Open Access | Times Cited: 162
A small molecule HIF-1α stabilizer that accelerates diabetic wound healing
Guodong Li, Chung-Nga Ko, Dan Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 159
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Zhenyi Hu, Craig M. Crews
ChemBioChem (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 159
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
Frances Potjewyd, Anne‐Marie W. Turner, Joshua Beri, et al.
Cell chemical biology (2019) Vol. 27, Iss. 1, pp. 47-56.e15
Open Access | Times Cited: 152
Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders
Meng Cheng, Xufen Yu, Kaylene Lu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 3, pp. 1216-1232
Open Access | Times Cited: 151
VH298-loaded extracellular vesicles released from gelatin methacryloyl hydrogel facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis
Yaxi Wang, Zhen Cao, Wei Qian, et al.
Acta Biomaterialia (2022) Vol. 147, pp. 342-355
Closed Access | Times Cited: 144
Page 1 - Next Page

Scroll to top